Stockscreener 앱 받기
88.13
4.60%
-4.25
시간 외 거래:
88.12
-0.010
-0.01%
전일 마감가:
$92.38
열려 있는:
$91.48
하루 거래량:
1.30M
Relative Volume:
1.01
시가총액:
$7.69B
수익:
순이익/손실:
$-386.19M
주가수익비율:
-16.77
EPS:
-5.2547
순현금흐름:
$-206.27M
1주 성능:
-0.02%
1개월 성능:
-13.79%
6개월 성능:
-28.04%
1년 성능:
-5.14%
1일 변동 폭
$86.85
$91.48
1주일 범위
$84.51
$92.81
52주 변동 폭
$69.81
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
88.13 | 7.69B | 0 | -386.19M | -206.27M | -5.2547 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-01 | 업그레이드 | Jefferies | Hold → Buy |
| 2026-06-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2026-06-02 | 업그레이드 | Wedbush | Underperform → Neutral |
| 2026-03-16 | 개시 | Jefferies | Buy |
| 2026-02-24 | 개시 | Wedbush | Outperform |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-06 | 개시 | Wolfe Research | Outperform |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-07-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-12-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-29 | 개시 | Laidlaw | Buy |
| 2024-05-20 | 개시 | BTIG Research | Buy |
| 2024-04-29 | 개시 | Guggenheim | Buy |
| 2024-04-29 | 개시 | Piper Sandler | Overweight |
| 2023-11-14 | 개시 | Leerink Partners | Outperform |
| 2023-11-14 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Abivax Adr 주식(ABVX)의 최신 뉴스
ABVX Q2 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Keeps Spending on Pipeline - https://www.dars.gov.et/
ABVX Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending ContinuesHealthcare Earnings Report - https://www.dars.gov.et/
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the GapDownward Estimate Revision - careplusvn.com
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the GapAnnual Earnings Summary - https://www.dars.gov.et/
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the GapForward Guidance Trends - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressLow Growth Earnings - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressEBITDA Estimate Trend - dars.gov.et
Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline ProgressRevenue Breakdown Analysis - dars.gov.et
Abivax (ABVX) Edges Up 0.92% to $120.04, Hovering at Range MidpointChart Pattern Alerts - dars.gov.et
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why - Yahoo Finance
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsBreadth Thrust - siam.in
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsWeekly Profile - careplusvn.com
Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum BuildsLate Stage Breakouts - dars.gov.et
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight - GlobeNewswire Inc.
Readystate Asset Management LP Raises Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Velan Capital Investment Management LP Sells 11,370 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Stock Holdings Increased by Seven Fleet Capital Management LP - MarketBeat
Abivax (ABVX) Quarterly Scorecard: Profit Per Share Falls Below Its Benchmark in the Reported Period - dars.gov.et
Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest TradingEPS Surprise History - careplusvn.com
Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest TradingEarnings Sentiment Score - dars.gov.et
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest SessionEarnings Quality Score - dars.gov.et
Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada - MarketBeat
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest SessionProduct Revenue Analysis - careplusvn.com
Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordIPO Entry Watch - careplusvn.com
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordLast Point Support - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordMoney Flow Index - dars.gov.et
Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available RecordPositive Gamma - dars.gov.et
Abivax (ABVX): TCG Crossover and Chen Yu report 7.0% ADS stake - Stock Titan
Abivax S.A. (ABVX) investors report 6.0% beneficial stake via Invus entities - Stock Titan
ABIVAX (NASDAQ:ABVX) Flashes Strong Technical Rating and Breakout Setup - ChartMill
Bank of America Corp DE Purchases 213,440 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Militia Capital Management LLC Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Perceptive Advisors LLC Cuts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Seven Fleet Capital Management LP Has $4.79 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com
Avidity Partners Management LP Takes $1.11 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Vivo Capital LLC - MarketBeat
ABVX Q4 2025 Earnings: Wider-than-Expected Net Loss, Shares Still Climb 4.62%Earnings Quality Score - www.dars.gov.et
Stempoint Capital LP Has $34.94 Million Stock Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – FWB:2X10 - TradingView
Ally Bridge Group NY LLC Lowers Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Eversept Partners LP Has $104.05 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Octagon Capital Advisors LP - MarketBeat
Orbimed Advisors LLC Has $51.86 Million Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Hsbc Holdings PLC Has $1.71 Million Stock Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Caxton Associates LLP Acquires Shares of 24,750 Abivax SA Sponsored ADR $ABVX - MarketBeat
Affinity Asset Advisors LLC Has $45.10 Million Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR Revenue Breakdown – SWB:2X10 - TradingView
Abivax SA Sponsored ADR $ABVX Position Increased by PSquared Asset Management AG - MarketBeat
Abivax Adr (ABVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Abivax Adr 주식 (ABVX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I SLP | Affiliate |
Oct 28 '25 |
Proposed Sale |
92.75 |
1,200,000 |
111,300,000 |
0 |
4.44%
자본화:
|
볼륨(24시간):